
Loading, please wait...

Loading, please wait...

In a real-world study of 17 patients, the overall response rate for melflufen-dexamethasone was 41%, demonstrating efficacy even in heavily pretreated populations.
The most frequent side effects are hematologic toxicities, including neutropenia (53%), thrombocytopenia (53%), and anemia (35%). Nonhematologic events such as infections and fatigue occur less frequently.
Yes, real-world data indicates that Melflufen is effective and has a manageable safety profile in elderly and fragile patients who may not be candidates for more intensive immunotherapies.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional recommendation. The information provided is based on specific research findings and should not replace the judgment of a healthcare professional. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


New real-world evidence from Bologna confirms that melflufen-dexamethasone is effective for heavily pretreated multiple myeloma patients with an ORR of 41%....
7 months ago

A prospective multicenter cohort study demonstrates that baseline health-related quality of life, particularly physical functioning, independently predicts all-cause maintenance hemodialysis mortality. Assessing patient-reported outcomes provides vital prognostic value beyond standard biochemical markers.
Today

Delhi is undergoing a major healthcare overhaul with enhanced Ayushman Bharat insurance up to ₹10 lakh, increased MBBS and PG medical training seats, expanded primary network mandirs, new tertiary neuro-ICUs, and public-private reproductive technology initiatives to build a resilient, preventative healthcare model.
Today

Aon forecasts India's healthcare inflation will ease to 10.1% in 2027 from 11.5% in 2026. Despite moderation, healthcare expenses continue to outpace general inflation, propelled by non-communicable diseases, advanced medical therapeutics, and expanding utilization patterns across diverse patient populations.
Today

Non-union fractures occur in 2-5% of cases, causing significant disability and cost. Conservative modalities such as LIPUS, PEMF, and focused ESWT offer non-surgical healing options for defects up to 5-10 mm when adequate mechanical stability exists without infection.
Today

Explore how novel oxygen-releasing PVA hydrogels prevent early post-transplant hypoxic damage in pancreatic beta cells, sustaining viability and insulin secretory function.
Today